Sell-Side Analyst's Predictions: UnitedHealth Group Incorporated (UNH), International Paper Company (IP)

Chase Investment Counsel Corp lowered its stake in UnitedHealth Group Inc.

UNH has been the topic of a number of research reports.

UnitedHealth Group Incorporated (NYSE:UNH), stock is trading $164.89 above the 52-week high and has displayed a high EPS growth of 8.90% in last 5 years. The number of shares now owned by investors are 150.26 mln.

07/20/2016 - UnitedHealth Group Incorporated had its " rating reiterated by analysts at RBC Capital. Over the past five trading sessions it is 2%; 3.75% for the month; 7.93% for the last quarter; 16.48% for the past six-months; and 41.76% for the last 12 months.

UnitedHealth Group Incorporated (NYSE:UNH) reported the earnings of $2.11/Share in the last quarter where the estimated EPS by analysts was $2.07/share. The fund owned 9,716 shares of the healthcare conglomerate's stock after buying an additional 732 shares during the period. Following the completion of the transaction, the director now directly owns 1,944,949 shares of the company's stock, valued at approximately $308,585,608.34. When we divide the current volume by the three-month average volume, we get a relative volume of 3.21. Finally, BlackRock Fund Advisors boosted its position in shares of UnitedHealth Group by 1.7% in the third quarter. Year-to-Date the stock performance stands at 2.26%. During the trading on 02/15/2017, Company's stock ranged from $162.58 to $164.89.

Receive UnitedHealth Group Incorporated News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated with's FREE daily email newsletter. Jefferies Group LLC boosted their target price on UnitedHealth Group from $168.00 to $182.00 and gave the stock a "buy" rating in a research report on Wednesday, November 30th.

The stock's price switched up -0.08% 20-Days Simple Moving Average, dropped -0.05% from 50-Days Simple Moving Average and rose 11.44% from 200 Days Simple Moving Average. Companys change in pay out ratio when compared to the last 5 years average pay out ratio has been 0.06. The company beat the analyst EPS Estimate with the difference of $0.04. The Market Capitalization of the company stands at 154.97 Billion. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. Sales growth past 5 years was measured at 12.70%. For the current year the company's revenue estimates are $198.93B compared to low analyst estimates of $196.43B and high estimates of $201.39B according to the projection of 16 analysts.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 21st. This represents a $2.50 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group's dividend payout ratio is presently 36.93%.

This piece of content was reported by BBNS and is the property of of BBNS. If you are accessing this news story on another site, it was copied illegally and reposted in violation of U.S. and global copyright and trademark law.

Several equities research analysts have weighed in on UNH shares. Cowen and Company set a $175.00 target price on UnitedHealth Group and gave the stock a "buy" rating in a research report on Wednesday, November 30th. The analysts believe that the company stock price could grow as high as $200. They now have a Dollars 164 price target on the stock.

11/30/2016 - UnitedHealth Group Incorporated was upgraded to " by analysts at Mizuho. Finally, Zacks Investment Research raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $180.00 target price on the stock in a research report on Saturday, December 3rd. One investment analyst has rated the stock with a hold rating and twenty-two have issued a buy rating to the company's stock.

There were more than a few analysts who recently mentioned the stock in their research.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business's stock in a transaction that occurred on Tuesday, February 14th. The stock was sold at an average price of $150.55, for a total transaction of $822,003.00.

  • Zachary Reyes